Related Experiment Video
Updated: Jan 24, 2026

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Published on: June 2, 2016
[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]
Michel Sabé1, Federico Seragnoli2, Louise Penzenstadler3
1Division de psychiatrie des adultes, département de psychiatrie, Hôpitaux universitaires de Genève, Thônex, Suisse. Faculté de médecine, université de Genève, Genève, Suisse. Division de psychiatrie des addictions, département de psychiatrie, Hôpitaux universitaires de Genève, Genève, Suisse.
Role Of Psychedelics In Psychiatry:
A TRUE THERAPEUTIC REVOLUTION OR A TREND? Psychedelics, long marginalized, are now gaining renewed interest in psychiatry for their therapeutic potential. Substances like psilocybin, LSD, and MDMA are being studied for treating conditions such as treatment-resistant depression, post-traumatic stress disorder (PTSD), and anxiety in palliative care. The FDA granted psilocybin "breakthrough therapy" status for certain indications in psychiatry, and progress has been made in Phase 3 clinical trials. However, the use of psychedelics carries risks, especially with non-medical use, including side effects. Stigmatization, their illegal status in many countries, and high costs limit accessibility. Despite promising results, the integration of these substances in psychiatry remains uncertain and raises ethical and societal concerns.
Related Concept Videos
True Stress and True Strain
In contrast, true stress offers a more precise portrayal. It is computed by dividing the...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Centroid for the Paraboloid of Revolution
The centroid for the paraboloid of revolution is the point where all the mass of the paraboloid is concentrated. This centroid is important for engineering applications, as it determines how forces are...
Current Trends in Nursing I
Current Trends in Nursing II
CNS Stimulants: Psychedelic Agents

